Compare Vanguard Information Technology Index Fund ETF (VGT) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vanguard Information Technology Index Fund ETF vs Health Care Select Sector SPDR Fund — how do they compare? Vanguard Information Technology Index Fund ETF trades at $127.94 (market cap $170.20B), while Health Care Select Sector SPDR Fund trades at $170.79 (market cap $43.48B). The key difference: Vanguard Information Technology Index Fund ETF is far larger — about 3.9× Health Care Select Sector SPDR Fund's market cap, and Vanguard Information Technology Index Fund ETF is trading nearer its 52-week high, Health Care Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vanguard Information Technology Index Fund ETF for 129 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| VGT | XLV | |
|---|---|---|
Market Cap | $170.20B | $43.48B |
Volume | 5,132,883 | 11,121,431 |
52-Week High | $129.79 | $175.68 |
52-Week Low | $83.59 | $141.95 |
Typical Hold Time | 129 Days | 100 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
VGT trades at $127.78, down 1.23% today but maintains a bullish technical outlook with strong moving average signals. The ETF, focused on U.S. technology stocks, has delivered exceptional historical returns, averaging over 17% annually. Recent news highlights its low expense ratio and concentration in tech giants like Nvidia, Apple, and Microsoft. A dividend of $0.15 is scheduled for September 2026.
Long-term growth prospects remain favorable given tech sector dominance and AI momentum, but risks include sector concentration, valuation concerns, and potential AI slowdown. Institutional ownership is increasing, with firms like Baird Financial raising stakes significantly. The current price near pivot point resistance at $128 suggests near-term consolidation before potential breakout.
XLV trades at $170.86, up 1.21% with a bearish technical signal from moving averages while oscillators remain neutral. The healthcare ETF shows strong cost advantages with a 0.08% expense ratio compared to peers, holding 61 diversified healthcare stocks from the S&P 500. Recent news highlights XLV's defensive characteristics during potential Fed rate hikes and political volatility.
The ETF offers defensive exposure to healthcare with low costs, though technical indicators suggest near-term pressure. Key risks include sector-specific regulatory changes and election uncertainty, while the fund's diversification provides stability amid market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vanguard Information Technology Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index/Information Technology 25/50, an index made up of stocks of large, mid-size, and small US companies within the information technology sector, as classified under the GICS. The advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VGT →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
